72792 Federal Register / Vol. 88, No. 203 / Monday, October 23, 2023 / Notices 

identified in ADDRESSES. Requests for 

repatriation may be submitted by: 

1. Any one or more of the Indian 

Tribes or Native Hawaiian organizations 

identified in this notice. 

2. Any lineal descendant, Indian 

Tribe, or Native Hawaiian organization 

not identified in this notice who shows, 

by a preponderance of the evidence, that 

the requestor is a lineal descendant or 

a culturally affiliated Indian Tribe or 

Native Hawaiian organization. 

Repatriation of the human remains in 

this notice to a requestor may occur on 

or after November 22, 2023. If 

competing requests for repatriation are 

received, the Field Museum must 

determine the most appropriate 

requestor prior to repatriation. Requests 

for joint repatriation of the human 

remains are considered a single request 

and not competing requests. The Field 

Museum is responsible for sending a 

copy of this notice to the Indian Tribe 

identified in this notice. 

Authority: Native American Graves 

Protection and Repatriation Act, 25 

U.S.C. 3003, and the implementing 

regulations, 43 CFR 10.9, 10.10, and 

10.14. 

Dated: October 11, 2023. 

Melanie O’Brien, 

Manager, National NAGPRA Program. 

[FR Doc. 2023–23278 Filed 10–20–23; 8:45 am] 

BILLING CODE 4312–52–P 

DEPARTMENT OF THE INTERIOR 

National Park Service 

[NPS–NERO–GATE–36747; PPNEGATEB0, 

PPMVSCS1Z.Y00000] 

Notice of Cancellation and 

Rescheduling of the Public Meeting of 

the Gateway National Recreation Area 

Fort Hancock 21st Century Advisory 

Committee; Correction 

AGENCY: National Park Service, Interior. 

ACTION: Notice; correction. 

SUMMARY: The National Park Service 

published in the Federal Register on 

October 2, 2023, a notice of public 

meeting of the Gateway National 

Recreation Area Fort Hancock 21st 

Century Advisory Committee scheduled 

for November 16, 2023. The document 

contained an incorrect date. The date of 

the meeting is November 9, 2023. 

FOR FURTHER INFORMATION CONTACT: 

Daphne Yun, Acting Public Affairs 

Officer, Gateway National Recreation 

Area, 210 New York Avenue, Staten 

Island, New York 10305, by telephone 

(718) 815–3651, or by email daphne_

yun@nps.gov. 

SUPPLEMENTARY INFORMATION: 

Correction 

In the Federal Register of October 2, 

2023, in FR Doc. 2023–21579 (88 FR 

67796), on page 67796, in the third 

column, correct the date of the 

Committee meeting to read: ‘‘Thursday, 

November 9, 2023.’’ 

Alma Ripps, 

Chief, Office of Policy. 

[FR Doc. 2023–23360 Filed 10–20–23; 8:45 am] 

BILLING CODE 4312–52–P 

INTERNATIONAL TRADE 

COMMISSION 

[USITC SE–23–050] 

Sunshine Act Meetings 

AGENCY HOLDING THE MEETING: United 

States International Trade Commission. 

TIME AND DATE: October 26, 2023 at 9:30 

a.m. 

PLACE: Room 101, 500 E Street SW, 

Washington, DC 20436, Telephone: 

(202) 205–2000. 

STATUS: Open to the public. 

MATTERS TO BE CONSIDERED: 

1. Agendas for future meetings: none. 

2. Minutes. 

3. Ratification List. 

4. Commission vote on Inv. No. 731– 

TA–921 (Fourth Review) (Folding Gift 

Boxes from China). The Commission 

currently is scheduled to complete and 

file its determinations and views of the 

Commission on November 3, 2023. 

5. Outstanding action jackets: none. 

CONTACT PERSON FOR MORE INFORMATION: 

Sharon Bellamy, Supervisory Hearings 

and Information Officer, 202–205–2000. 

The Commission is holding the 

meeting under the Government in the 

Sunshine Act, 5 U.S.C. 552(b). In 

accordance with Commission policy, 

subject matter listed above, not disposed 

of at the scheduled meeting, may be 

carried over to the agenda of the 

following meeting. 

By order of the Commission. 

Issued: October 19, 2023. 

Sharon Bellamy, 

Supervisory Hearings and Information 

Officer. 

[FR Doc. 2023–23419 Filed 10–19–23; 11:15 am] 

BILLING CODE 7020–02–P 

JOINT BOARD FOR THE 

ENROLLMENT OF ACTUARIES 

Advisory Committee on Actuarial 

Examinations; Vacancy 

AGENCY: Joint Board for the Enrollment 

of Actuaries. 

ACTION: Request for applications. 

SUMMARY: The Joint Board for the 

Enrollment of Actuaries (Joint Board), 

established under the Employee 

Retirement Income Security Act of 1974 

(ERISA), is responsible for the 

enrollment of individuals who wish to 

perform actuarial services under ERISA. 

To assist in its examination duties 

mandated by ERISA, the Joint Board has 

established the Advisory Committee on 

Actuarial Examinations (Advisory 

Committee) in accordance with the 

provisions of the Federal Advisory 

Committee Act (FACA). The current 

Advisory Committee members’ terms 

expire on February 28, 2025. Recently, 

a vacancy became available on the 

Advisory Committee, and the Joint 

Board seeks applications to fill that 

vacancy. This notice describes the 

Advisory Committee and invites 

applications from those interested in 

serving on the Advisory Committee for 

the period March 1, 2024–February 28, 

2025. 

DATES: Applications for membership on 

the Advisory Committee must be 

received by December 1, 2023. 

ADDRESSES: Send applications 

electronically with APPLICATION FOR 

ADVISORY COMMITTEE inserted in 

subject line to NHQJBEA@irs.gov. See 

SUPPLEMENTARY INFORMATION for 

application requirements. 

FOR FURTHER INFORMATION CONTACT: 

Elizabeth Van Osten, Designated Federal 

Officer, Advisory Committee on 

Actuarial Examinations, at 202–317– 

3648 or elizabeth.j.vanosten@irs.gov. 

SUPPLEMENTARY INFORMATION: 

1. Background 

To qualify for enrollment to perform 

actuarial services under ERISA, an 

applicant must satisfy certain 

experience and knowledge 

requirements, which are set forth in the 

Joint Board’s regulations. An applicant 

may satisfy the knowledge requirement 

by successful completion of Joint Board 

examinations in basic actuarial 

mathematics and methodology and in 

actuarial mathematics and methodology 

relating to pension plans qualifying 

under ERISA. 

The Joint Board, the Society of 

Actuaries, and the American Society of 

Pension Professionals & Actuaries 

jointly offer examinations acceptable to 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 203 / Monday, October 23, 2023 / Notices 72793 

the Joint Board for enrollment purposes 

and acceptable to the other two actuarial 

organizations as part of their respective 

examination programs. 

2. Scope of Advisory Committee Duties 

The Advisory Committee plays an 

integral role in the examination program 

by assisting the Joint Board in offering 

examinations that enable examination 

candidates to demonstrate the 

knowledge necessary to qualify for 

enrollment. The Advisory Committee’s 

duties, which are strictly advisory, 

include (1) recommending topics for 

inclusion on the Joint Board 

examinations, (2) developing and 

reviewing examination questions, (3) 

recommending proposed examinations, 

(4) reviewing examination results and 

recommending passing scores, and (5) 

providing other recommendations and 

advice relative to the examinations, as 

requested by the Joint Board. 

3. Member Terms and Responsibilities 

Generally, members are appointed for 

a 2-year term. However, the member 

selected pursuant to this notice will be 

appointed for 12 months, beginning 

March 1, 2024. Members may seek 

reappointment for additional 

consecutive terms. 

Members are expected to attend 

approximately 4 meetings each calendar 

year and are reimbursed for travel 

expenses in accordance with applicable 

government regulations. For this 

appointment, the member is expected to 

attend approximately 4 meetings. 

Meetings may be held in-person or by 

teleconference. In general, members are 

expected to devote 125 to 175 hours, 

including meeting time, to the work of 

the Advisory Committee over the course 

of a year. 

4. Member Selection 

The Joint Board seeks to appoint an 

Advisory Committee that is fairly 

balanced in terms of points of view 

represented and functions to be 

performed. Every effort is made to 

ensure that most points of view extant 

in the enrolled actuary profession are 

represented on the Advisory Committee. 

To that end, the Joint Board seeks to 

appoint members from each of the main 

practice areas of the enrolled actuary 

profession, including small employer 

plans, large employer plans, and 

multiemployer plans. In addition, to 

ensure diversity of points of view, the 

Joint Board limits the number of 

members affiliated with any one 

actuarial organization or employed with 

any one firm. 

Membership normally will be limited 

to actuaries currently enrolled by the 

Joint Board. However, individuals 

having academic or other special 

qualifications of particular value for the 

Advisory Committee’s work also will be 

considered for membership. Federally 

registered lobbyists and individuals 

affiliated with Joint Board enrollment 

examination preparation courses are not 

eligible to serve on the Advisory 

Committee. 

5. Member Designation 

Advisory Committee members are 

appointed as Special Government 

Employees (SGEs). As such, members 

are subject to certain ethical standards 

applicable to SGEs. Upon appointment, 

each member will be required to 

provide written confirmation that he/ 

she does not have a financial interest in 

a Joint Board examination preparation 

course. In addition, each member will 

be required to attend annual ethics 

training. 

6. Application Requirements 

To receive consideration, an 

individual interested in serving on the 

Advisory Committee must submit (1) a 

signed, cover letter expressing interest 

in serving on the Advisory Committee 

and describing his/her professional 

qualifications, and (2) a resume and/or 

curriculum vitae. Applications must be 

submitted electronically to NHQJBEA@

irs.gov. The transmittal email should 

include APPLICATION FOR ADVISORY 

COMMITTEE in the subject line. 

Applications must be received by 

December 1, 2023. 

Dated: October 18, 2023. 

Thomas V. Curtin, Jr., 

Executive Director, Joint Board for the 

Enrollment of Actuaries. 

[FR Doc. 2023–23328 Filed 10–20–23; 8:45 am] 

BILLING CODE 4830–01–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1284] 

Importer of Controlled Substances 

Application: Nexus Pharmaceuticals, 

Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Nexus Pharmaceuticals, Inc. 

has applied to be registered as an 

importer of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before November 22, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before November 22, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on September 20, 2023, 

Nexus Pharmaceuticals, Inc., 10300 

128th Avenue, Pleasant Prairie, 

Wisconsin 53158–7336 applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Remifentanil .................. 9739 II 

The company plans to import the 

listed controlled substance for research 

and analytical testing purposes. No 

other activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonVerDate Sep<11>2014 17:24 Oct 20, 2023 Jkt 262001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\23OCN1.SGM 23OCN1

lotter on DSK11XQN23PROD with NOTICES1